Novo Nordisk A/S - share repurchase programme
November 06, 2023 15:56 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 November 2023 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2023 of DKK 30 billion continues. As part of this, Novo Nordisk A/S has now initiated a...
Novo Nordisk A/S purchases B shares worth DKK 4,886 million from Novo Holdings A/S under the 2023 share repurchase programme
November 06, 2023 15:49 ET
|
Novo Nordisk A/S
Novo Nordisk A/S purchases B shares worth DKK 4,886 million from Novo Holdings A/S under the 2023 share repurchase programm – Today, Novo Nordisk A/S has entered into an agreement to purchase...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
November 06, 2023 08:40 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 6 November 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
November 03, 2023 10:18 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 3 November 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk's sales increased by 29% in Danish kroner and by 33% at constant exchange rates to DKK 166.4 billion in the first nine months of 2023
November 02, 2023 02:30 ET
|
Novo Nordisk A/S
Bagsværd 2 November 2023 - Financial report for the period 1 January 2023 to 30 September 2023 ...
Novo Nordisk A/S - share repurchase programme
November 01, 2023 12:04 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 1 November 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
October 23, 2023 08:51 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 23 October 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S – Share repurchase programme
October 16, 2023 08:09 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 16 October 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences
October 16, 2023 07:00 ET
|
Novo Nordisk A/S
Bagsværd, Denmark and Singapore, 16 October 2023 – Novo Nordisk A/S and KBP Biosciences PTE., Ltd. today announced that Novo Nordisk has agreed to acquire ocedurenone for uncontrolled hypertension...
Novo Nordisk raises sales and operating profit outlook for 2023
October 13, 2023 08:48 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 13 October 2023 – Novo Nordisk today announced that the sales and operating profit growth at constant exchange rates (CER) for the first nine months of 2023 and that the full-year...